Soumit Roy, Ph.D., is Vice President, Healthcare Analyst of Jones Trading Institutional Services LLC. Dr. Roy is responsible for research coverage on biotechnology companies within the healthcare sector for Jones Trading. Prior to joining Jones Trading in 2018, Dr. Roy was a senior research associate at SunTrust Robinson Humphrey, covering small- and mid-cap biotechnology companies with innovative technologies, notably T-cell therapy, targeted medicines, gene editing and next-generation immuno-oncology. He was a postdoctoral fellow at the Icahn School of Medicine at Mount Sinai, New York, in the Clinical Immunology Department, and his research was focused on understanding and discovering novel agents to improve vaccines. He earned his Ph.D. from the Albert Einstein College of Medicine, New York, where he helped to develop a novel drug candidate that targets the powerhouse of cancer cells to stop cancerous growth. He holds two master’s degrees, in developmental biology and biochemistry, and has published in the highest-rated scientific journals.
Benjamin Nolan, CFA, is a Managing Director in the Transportation sector, covering Shipping and Energy Infrastructure at Stifel Financial Corp. Mr. Nolan joined the firm in 2013. Before joining Stifel, he covered both equity and debt of companies in the maritime sector at Knight Capital. He also spent six years at Jefferies as an Equity Research Analyst covering the shipping sector and spent several years as a corporate Financial Analyst for EOG Resources in the oil and gas business. He received a BBA degree in finance from Texas A&M University and an MBA from the University of Houston. Mr. Nolan has won numerous StarMine and Institutional Investor awards for stock picking, earning estimating, and research analysis.
Eric Compton is Equity Analyst of Morningstar, Inc. Mr. Compton is an experienced equity analyst who covers the U.S. money center and regional banks and Canadian banks. In his work at Morningstar, he focuses on long-term competitive advantages and cash-flow-based valuation. Prior to being with Morningstar, he was a business analyst with ESIS from 2012 to 2015. He is a graduate of Wheaton College.
James Prescott Beury, also known as Scott, is a Research Analyst at Boenning & Scattergood, Inc. He covers the financial services sector and is specifically focused on small- and mid-cap banks headquartered in the Midwest region. Previously, Mr. Beury served as a research associate at the firm, assisting with coverage of banks in the Mid-Atlantic and Northeast regions.
Laurie Havener Hunsicker is Managing Director and Research Analyst at Compass Point Research & Trading LLC. Ms. Hunsicker is a Managing Director and senior equity analyst at Compass Point Research & Trading covering small regional banks, community banks and thrift conversions, with a geographic focus on the Northeast, Mid-Atlantic and Hawaii. She is well-known in the financial services investment community for providing in-depth, fundamental analysis and equity research with a career as a senior equity analyst that spans 28 years. Prior to joining the Compass Point equity research team in January 2014, Ms. Hunsicker spent four years at Stifel, Nicolaus & Company as a managing director and senior analyst in bank equity research covering Northeast and Mid-Atlantic community banks, thrift conversions; prior to Stifel, Ms. Hunsicker spent 17 years at FBR, including 15 years as a senior analyst, covering community banks, regional banks and thrifts conversions across the U.S. but with a geographic concentration in the Northeast, Mid-Atlantic and Southeast. At FBR, Ms. Hunsicker was a managing director and, for the final 10 years of her tenure, was co-head of FIG research. Ms. Hunsicker has received more Top Stock Picking Awards of Excellence by Thomson Reuters/StarMine in both the categories of Thrifts & Mortgage Finance and Banks, combined, than any other U.S. equity sellside analyst since StarMine started publishing awards in 2002.
Anthony Polini is the Director of Research at American Capital Partners, LLC where he specializes in the banking industry. Mr. Polini was previously a sellside analyst at Raymond James Financial. Prior to that, he served at Midwest Research, A.G. Edwards and Prudential Securities He has received numerous professional accolades and has been frequently quoted by the press. He has appeared regularly on CNBC, as well as various TV news and business programs. He earned his B.A. in psychology and philosophy from the University of Pennsylvania and has an MBA in finance from St. John’s University.
Richard Xavier Bove is the Chief Financial Strategist at Rafferty Capital Markets. Mr. Bove began his career on Wall Street as a retail salesperson at legacy Eastman Dillon Union Securities in late 1965. He joined Wertheim & Co. in 1971 as an analyst covering the building and banking industries. Later, Mr. Bove became the Director of Research at C.J. Lawrence and Raymond James. In the mid-1980s, he returned to the analytical profession as a banking and financial analyst serving at Raymond James, Dean Witter Reynolds, Lehman Brothers and Ladenburg Thalmann, among other firms in his 53 years in the industry. In 2013, Mr. Bove joined Rafferty Capital Markets. In 2018, he was selected to be the firm’s Chief Financial Strategist. Mr. Bove has been interviewed on television over 1,500 times and his print interviews now number over 10,000. His views have been reported on in Europe, Asia and Latin America. He holds a bachelor’s degree from Columbia College where he graduated in 1962. He has been married 52 years and has seven children and 21 grandchildren.
Marty Mosby is Director of Banking and Equity Strategies at Vining Sparks IBG, LP, Research Division. Mr. Mosby has been, since July 8, 2014, at Vining Sparks where he covers large-cap banks at the firm. Prior to this, Mr. Mosby was an analyst at Guggenheim Securities, LLC, Research Division. He was employed at the firm until June 2014 and covered the financial industry group. Previously, Mr. Mosby was a senior research analyst at FTN Midwest Securities Corp., Research Division since November 2008. Before that, he was the Chief Financial Officer and Executive Manager at First Horizon National Corporation from 2003 to 2007. Mr. Mosby was also the Head of Investor Relations and Strategic Planning, ALCO Chairperson and Chief Economist at the firm. As Chief Financial Officer, he directed the Treasury, Tax, Controller, Merger and Acquisition, Strategic Planning and Investor Relations Departments. Mr. Mosby helped First Horizon National Corporation acquire or divest more than 25 companies and raised over $1.5 billion in capital. Prior to this, he was in strategic planning and investor relations from 1994 to 2003, and in asset and liability management from 1988 to 1994. Mr. Mosby was ranked first by Integrity Research and Investors’ performance, won Bank Analyst Annual Best Investor Relations at a Mid-Cap Bank award twice and was recognized by Investor Relations Magazine for one of the best roadshows of any midsize company. Mr. Mosby received a master’s degree in economics from the University of Pennsylvania and a bachelor’s degree in economics from The University of Memphis.
Rick Weiss is Chief Bank Strategist of Ambassador Financial Group. Mr. Weiss joined Ambassador Financial Group in 2015 as Managing Director, Head of Investor Relations. Selected by Forbes and Starmine in 2015, 2010 and 2006, Mr. Weiss is recognized as one of the top stock-pickers for the thrift and mortgage finance industry. He was also named by The Wall Street Journal as “Best on the Street.” Mr. Weiss is regarded as an industry expert and is often quoted in financial media outlets, including The Wall Street Transcript, Dow Jones News, American Banker and SNL Financial. He was a Director of Banks and Thrifts in the research department at Janney Montgomery Scott, LLC, and Senior Bank Analyst at Boenning & Scattergood, Inc. He also worked in the corporate finance department at Ryan, Beck, and Co. and started his career at the U.S. Securities and Exchange Commission.
Steven Seedhouse, Ph.D., is Vice President, Equity Research, Biotechnology at Raymond James Financial, Inc. Dr. Seedhouse has been a biotech equity research analyst or an associate at various firms since 2015. He joined Raymond James in March 2018. Prior to his career in equity research, Dr. Seedhouse completed a Ph.D. in pharmacology from Roswell Park Cancer Institute in Buffalo, New York, and holds an M.S. in medicinal chemistry from SUNY Buffalo.
